Background {#Sec1}
==========

The lipopolysaccharide (LPS) of shigellae is known to exhibit a high degree of antigenic diversity. This diversity arises primarily from differences in the structure and composition of the O-antigen. *S. flexneri* serotypes (with the exception of serotype 6) contain the same basic O-antigen backbone, namely a repeating tetrasaccharide unit made up of one N-acetylglucosamine residue (Glc*N*Ac) and three rhamnose residues (RhaI, RhaII and RhaIII). Currently, there are at least 15 established *S. flexneri* serotypes, including the newly designated 1c and 7b subtypes \[[@CR1]\], all of which are capable of causing shigellosis. There are also a few more putative new serotypes which are yet to be considered for possible official classification \[[@CR2], [@CR3]\]. Each of these serotypes contains a specific LPS-O antigen that is responsible for its particular serotype characteristics.

Serotype 1c, also known as 7a subtype of *S. flexneri*, emerged in the 1990s. The presentation of O-antigens in serotype 1c is unique, as it is the first example in which an α-D-Glcp-(1➔2)-α-D-Glcp-(termed kojibiosyl) group is added to the basic repeating unit of O-antigen \[[@CR4]\]. Serotype 1c contains a disaccharide linked to the N-acetyleglucosamine in the basic tetrasaccharide repeating units, whereas serotype 1a and 1b strains contain only a single glucosyl group at the same site (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1The chemical structure of the repeating tetrasaccharide units in the O-antigen of *S.flexneri* serotypes 1a, 1b and 1c

The genetic mechanism responsible for O-antigen modification in serotype 1c was first elucidated by Stagg et al. \[[@CR5]\]. The addition of the first glucosyl group is mediated by the previously characterised *gtrI* cluster found within a cryptic prophage at the *proA* locus in the bacterial chromosome. Transposon mutagenesis, performed to disrupt the gene responsible for the addition of the second glucosyl group, successfully identified the gene encoding the serotype 1c --specific O-antigen modification, which was designated as *gtrIC*. The *gtrIC* gene was present as part of a three gene cluster, arranged in a similar way to the *gtr* clusters present in other *S. flexneri* serotypes.

Adhikari et al. \[[@CR6]\] earlier concluded that *gtrI* was integrated into *S. flexneri* by a bacteriophage via the tRNA^ThrW^*proA* site. Our preliminary analysis of the sequence adjacent to the *gtrIC* cluster suggested the possibility of another integration site for serotype 1c prophage \[[@CR5]\]. We hypothesized that serotype 1c strains arose, following the introduction of the *gtrIC* gene cluster, via a second bacteriophage that got inserted into a separate location on the chromosome of an ancestral serotype 1a strain. In this study, we show that serotype 1c strains are genetically related through conserved *gtrIC* sequences, and that serotype 1c isolates share an identical pattern of genetic arrangement despite their different geographical origins. In addition, we report the identification of a new site for the integration of the serotype converting phages of the *S. flexneri* serotype 1c strain. The experiments and sequence analyses performed in this study provide further insights into the origin of this serotype.

Methods {#Sec2}
=======

Bacterial culturing conditions and media {#Sec3}
----------------------------------------

The *S. flexneri* strains used in the study are listed in Table [1](#Tab1){ref-type="table"}. Bacteria were grown aerobically (≅180-200 RPM) at 37 °C in Luria-Bertani (LB) broth or on LB agar supplemented with appropriate antibiotics. Unless stated otherwise, antibiotics (Sigma-Aldrich) were added at the following final concentrations: ampicillin (100 μg/mL); chloramphenicol (25 μg/mL); tetracycline (10 μg/mL); and kanamycin (50 μg/mL).Table 1Wild type *S. flexneri* strains used in this studyStrainsDerivation/other namesReferenceDescriptionSFL1416NCTC \#3NCTCSerotype 1a strain from NCTC (The National Collection of Type Cultures) London, UKSFL1417NCTC \#5NCTCSerotype 1b strain from NCTC (The National Collection of Type Cultures) London, UKBangladeshSFL1492K-480\[[@CR19]\]Serotype 1b strain isolated in BangladeshSFL1493K-647\[[@CR19]\]Serotype 1a strain isolated in BangladeshSFL1496K-218\[[@CR19]\]Serotype 1b strain isolated in BangladeshSFL1499K-143\[[@CR19]\]Serotype 1b strain isolated in BangladeshSFL1501K-265\[[@CR19]\]Serotype 1c strain isolated in BangladeshSFL1504K-212\[[@CR19]\]Serotype 1c strain isolated in BangladeshSFL1613Y394\[[@CR4]\]Serotype 1c strain isolated in BangladeshEgyptSFL1683ALX1592\[[@CR20]\]Serotype 1c strain isolated in EgyptSFL1684ALX1592\[[@CR20]\]Serotype 1c strain isolated in EgyptSFL1685ALX1869\[[@CR20]\]Serotype 1c strain isolated in EgyptSFL1686ALX1929\[[@CR20]\]Serotype 1c strain isolated in EgyptSFL1687ALX1930\[[@CR20]\]Serotype 1c strain isolated in EgyptSFL1688ALX1938\[[@CR20]\]Serotype 1c strain isolated in EgyptSFL1689ALX2463\[[@CR20]\]Serotype 1c strain isolated in EgyptSFL1690ALX2539\[[@CR20]\]Serotype 1c strain isolated in EgyptSFL1691ALX3216\[[@CR20]\]Serotype 1c strain isolated in EgyptSFL1692ALX3326\[[@CR20]\]Serotype 1c strain isolated in EgyptJapanSFL1276850325-1331C. SasakawaSerotype 1b strain isolated in JapanSFL12871649-17C. SasakawaSerotype 1b strain isolated in JapanSFL12881649-18C. SasakawaSerotype 1a strain isolated in JapanSFL13001649-30C. SasakawaSerotype 1b strain isolated in JapanVietnamSFL1564737\[[@CR21]\]Serotype 1c (rough) strain isolated in Vietnam (Son Tay Province)SFL1568774\[[@CR21]\]Serotype 1c (rough) strain isolated in Vietnam (Son Tay Province)SFL1569784\[[@CR21]\]Serotype 1c strain isolated in Vietnam (Son Tay Province)SFL1570786\[[@CR21]\]Serotype 1c (rough) strain isolated in Vietnam (Son Tay Province)SFL1571790\[[@CR21]\]Serotype 1c strain isolated in Vietnam (Son Tay Province)SFL15751216\[[@CR21]\]Serotype 1c strain isolated in Vietnam (Son Tay Province)SFL15761217\[[@CR21]\]Serotype 1c (rough) strain isolated in Vietnam (Son Tay Province)SFL15771233\[[@CR21]\]Serotype 1c (rough) strain isolated in Vietnam (Son Tay Province)SFL15781240\[[@CR21]\]Serotype 1c strain isolated in Vietnam (Son Tay Province)SFL15791244\[[@CR21]\]Serotype 1c strain isolated in Vietnam (Son Tay Province)SFL15801245\[[@CR21]\]Serotype 1c strain isolated in Vietnam (Son Tay Province)SFL15811247\[[@CR21]\]Serotype 1c strain isolated in Vietnam (Son Tay Province)SFL15821248\[[@CR21]\]Serotype 1c strain isolated in Vietnam (Son Tay Province)SFL15831249\[[@CR21]\]Serotype 1c (rough) strain isolated in Vietnam (Son Tay Province)SFL15841250\[[@CR21]\]Serotype 1c (rough) strain isolated in Vietnam (Son Tay Province)SFL15851251\[[@CR21]\]Serotype 1c strain isolated in Vietnam (Son Tay Province)SFL15861274\[[@CR21]\]Serotype 1c strain isolated in Vietnam (Son Tay Province)SFL15871292\[[@CR21]\]Serotype 1c (rough) strain isolated in Vietnam (Son Tay Province)SFL15881367\[[@CR21]\]Serotype 1c strain isolated in Vietnam (Son Tay Province)SFL15891387\[[@CR21]\]Serotype 1c strain isolated in Vietnam (Son Tay Province)SFL15901400\[[@CR21]\]Serotype 1c strain isolated in Vietnam (Son Tay Province)SFL15941432\[[@CR21]\]Serotype 1c strain isolated in Vietnam (Son Tay Province)SFL15951440\[[@CR21]\]Serotype 1c (rough) strain isolated in Vietnam (Son Tay Province)SFL15961447\[[@CR21]\]Serotype 1c strain isolated in Vietnam (Son Tay Province)SFL15971502\[[@CR21]\]Serotype 1c strain isolated in Vietnam (Son Tay Province)SFL15981587\[[@CR21]\]Serotype 1c strain isolated in Vietnam (Son Tay Province)SFL16001607\[[@CR21]\]Serotype 1c strain isolated in Vietnam (Son Tay Province)SFL16021670\[[@CR21]\]Serotype 1c strain isolated in Vietnam (Son Tay Province)SFL16031702\[[@CR21]\]Serotype 1c strain isolated in Vietnam (Son Tay Province)SFL16041711\[[@CR21]\]Serotype 1c (rough) strain isolated in Vietnam (Son Tay Province)SFL16051733\[[@CR21]\]Serotype 1c strain isolated in Vietnam (Son Tay Province)SFL16061804\[[@CR21]\]Serotype 1c strain isolated in Vietnam (Son Tay Province)SFL16071921\[[@CR21]\]Serotype 1c strain isolated in Vietnam (Son Tay Province)SFL16102238\[[@CR21]\]Serotype 1c strain isolated in Vietnam (Son Tay Province)SFL1556NB1\[[@CR22]\]Serotype 1c strain isolated in Vietnam (Nha Trang province)SFL1557NB2\[[@CR22]\]Serotype 1c strain isolated in Vietnam (Nha Trang province)SFL1558NB7\[[@CR22]\]Serotype 1c strain isolated in Vietnam (Nha Trang province)SFL1561NB545\[[@CR22]\]Serotype 1c strain isolated in Vietnam (Nha Trang province)SFL1562NB644\[[@CR22]\]Serotype 1c strain isolated in Vietnam (Nha Trang province)SFL1565747\[[@CR22]\]Serotype 1c strain isolated in Vietnam (Nha Trang province)SFL1566749\[[@CR22]\]Serotype 1c strain isolated in Vietnam (Nha Trang province)SFL1567752\[[@CR22]\]Serotype 1c strain isolated in Vietnam (Nha Trang province)SFL15721097\[[@CR22]\]Serotype 1c strain isolated in Vietnam (Nha Trang province)SFL15731127\[[@CR22]\]Serotype 1c strain isolated in Vietnam (Nha Trang province)SFL15991588\[[@CR22]\]Serotype 1c strain isolated in Vietnam (Nha Trang province)SFL1712481NT2\[[@CR22]\]Serotype 1c strain isolated in Vietnam (Nha Trang province)

Serotyping {#Sec4}
----------

The serological features of the *S. flexneri* strains were determined by slide agglutination. A sterile loop was used to mix bacteria from LB agar plates with a drop of antibody on a glass slide. The slide was gently agitated while observing for agglutination. Negative controls were performed using 0.9 % NaCl instead of antibody. Isolates were tested using both commercially available monovalent antisera (Denka Seiken, Tokyo, Japan) and the monoclonal antibody reagent MASF Ic (Reagensia AB, Sweden) directed against type-specific somatic and group O factor antigens of *S. flexneri*.

DNA techniques {#Sec5}
--------------

Genomic DNA was isolated from an overnight culture using the Illustra™ bacteria Genomic Prep Mini Spin Kit (GE healthcare) in accordance with the manufacturer's instructions. Oligonucleotide primers used for PCR were synthesized by Sigma-Aldrich (Australia), and are listed in Table [2](#Tab2){ref-type="table"}. PCR was performed using PfuUltra II Fusion HS DNA Polymerase (Stratagene) in accordance with the manufacturer's instructions. Purification of the PCR products was achieved using the Wizard SV Gel and PCR Clean Up system (Promega, Maddison, Wisconsin, USA). DNA sequencing was performed using the Big Dye Version 3.1 sequencing protocol, and was analysed with the ABI 3730 capillary sequence analyser at the Biomolecular Resources Facility, John Curtin School of Medical Research, Australian National University. Digestion of the DNA was performed using enzymes supplied by Fermentas.Table 2Primers used in this studyPrimer nameSequenceDescriptionGtrIc-F(BamHI)^a^TTAGGATCCAGGGATTCAACTGATTGGCBinds upstream of *gtrIC* (in *gtrB* ~*IC*~).GtrIcR2-BamHITGAGGATCCGACAGGATCAATCACCGCBinds downstream of *gtrIC* stop codon.DG_GtrA(Ic)F(SacI) ^b^GTCGAGCTCTTGATGCTAAACTCTCACTTTBinds to sequence 24--44 bp upstream of *gtrA* ~*IC*~ start codon^a^Primer pair of GtrIc-F(BamHI) and GtrIc-R2(BamHI), was optimal for the production of a single band which corresponded to the *gtrIC* gene^b^Primer pair of DG_GtrA(Ic)F(SacI) and GtrIc-R2(BamHI) was the best choice for the *gtrIC* gene cluster

Bioinformatics analysis {#Sec6}
-----------------------

The DNA sequence was analysed for the presence of ORFs and *tRNA* genes using the open access software programmes myRAST (RASTserver.pm), CLC Main workbench 6.7 (CLCbio) and NCBI ORF finder, followed by manual inspection of the start codons and ribosome binding sequences of each ORF. Genes within ORFs were predicted based on homologies to known genes found by BLASTn and BLASTp searches, as well as by the presence of Shine-Dalgarno ribosome binding sites. The corresponding proteins were compared with the non-redundant protein database using the BLASTp and BLASTx programmes available from the National Centre for Biotechnology Information ([http://www.ncbi.nlm.nih.gov](http://www.ncbi.nlm.nih.gov/)). The protein level alignments were performed using CLUSTAL W \[[@CR7]\] and BioEdit Sequence Alignment Editor \[[@CR8]\].

Southern blotting {#Sec7}
-----------------

Genomic DNA digestion was achieved by using DNA (1000 ng) in a total volume of 100 μl overnight digestion, with an appropriate restriction enzyme. Following an agarose gel electrophoresis of the digested genomic DNA samples, the DNA was transferred to a Hybond N+ nucleic acid transfer membrane (Amersham Biosciences) through capillary action. A *DIG* High Prime DNA Labelling and Detection Kit (Roche) was used to generate Digoxigenin (*DIG*) -- labelled DNA probe. Hybridization of the membrane as well as detection were performed according to the kit manufacturer's instructions. The membrane was viewed under a Fusion Chemiluminescence Camera (Fisher Biotech).

Results and discussion {#Sec8}
======================

Serotype 1c strains have a conserved *gtrIC* sequence {#Sec9}
-----------------------------------------------------

Until now, very little has been known about the extent of *gtrIC* conservation among *S. flexneri* 1c strains from different regions of the world. Therefore, in order to study the *gtrIC* homology and the prevalence of the putative *gtrIC* variants in various 1c isolates of patients from different ethnic and geographic origins, PCR was employed to detect the presence of the *gtrIC* gene. This was done concurrently with conventional agglutination tests. All strains which had positive serotype 1c agglutination results also produced a PCR amplicon of 1769 nt, corresponding to the presence of the *gtrIC* gene. As shown in Fig. [2](#Fig2){ref-type="fig"}, a PCR product of the same size was also produced in a rough serotype 1c strain which did not express serotype 1c specific O-antigen, and which therefore could not be typed by antisera. Furthermore, sequencing of the PCR amplicon in which the whole *gtrIC* cluster was amplified by primer pair of DG_GtrA(Ic)F(SacI) and GtrIc-R2(BamHI), revealed that the *gtrA*~*Ic*~ and *gtrB*~*Ic*~ genes from all the representative strains were exactly identical to each other. The results revealed that the serotype 1c strains had 100 % identical *gtrIC* gene nucleotide sequences as well as 100 % nucleotide identity for the whole *gtrIC* clusters (*gtrA*~*Ic*~*, gtrB*~*Ic*~ and *gtrIC* genes). This means that extreme conserved nucleotide sequences exist not only in the *gtrIC* locus, but also in the whole *gtrIC* cluster.Fig. 2Detection of serotype 1c strains among a variety of *S. flexneri* strains using PCR amplification with the *gtrIC* specific primer pair. Amplification of *gtrIC* gene cluster product was visualised under UV light following agarose gel electrophoresis in the presence of ethidium bromide. Lane:1. SFL1416, serotype 1a; 2. SFL1253, serotype 4a; 3. SFL1613, serotype 1c strain isolated from Bangladesh; 4. SFL1501, serotype 1c strain isolated from Bangladesh; 5. SFL1569, serotype 1c strain isolated from Vietnam; 6. SFL1564, rough strain isolated from Vietnam; 7. SFL1683, serotype 1c strain isolated from Egypt;8. SFL1504, serotype 1c strain isolated from Bangladesh; 9. H~2~O control. 10. Expected sizes of PCR products are indicated by a red arrow, which was estimated using the DNA marker, SPPI

The only exception to the above was SFL1501, which contained the *gtrIC* gene with a 6-bp deletion (GAAATG). Interestingly, this deletion was one of four GAAATG repeats present at the 3′ terminus of *gtrIC* gene (Fig. [3](#Fig3){ref-type="fig"}). Perhaps the absence of one of the four repeats of tryptophan-lysine residues at the C-terminus does not affect the overall function of the GtrIc. It is possible that sequence redundancy and the repeated sequences compensate for this loss.Fig. 3The comparison of the 3′ end of *gtrIC* sequence of SFL1501 to the published *gtrIC* sequence of SFL1613. The repeating GAAATG feature in both sequences. TGA depicts a stop codon

Based on the fact that a conserved nucleotide sequence exists and no silent mutation was detected in *gtrIC* and its cluster sequence, we speculate that Type 1c modification plays a vital role within *S. flexneri*, and may assist the bacteria to a certain extent in the invasion of the epithelial cells of the host organism.

Serotype 1c isolates share an identical pattern of genetic arrangement despite differing geographical origins {#Sec10}
-------------------------------------------------------------------------------------------------------------

Southern blotting with the *gtrIC* probe was used to reveal the upstream and downstream organization and distribution of the *gtrIC* gene cluster in different strains of *S. flexneri* serotype 1c. If the upstream and downstream organization of the *gtrIC* gene cluster are the same, two fragments should be expected with *Eco*32I digestion and one fragment for *Bam*HI digestion. If, on the other hand, there are any differences between the organization of the upstream and downstream regions, fragments of variable sizes should be produced. These data should not only cast light on the organization of the upstream and downstream of *gtrIC* gene clusters in different strains, but also allow the determination of the number of copies of the *gtrIC* locus present in the genome of various 1c isolates.

A total of sixty-nine different serotype 1c isolates, obtained from Bangladesh, Egypt and Vietnam, were screened. The *Eco*321-digested genomic DNA of all the serotype 1c strains, when probed with *gtrIC*, showed two bands: a 7784 bp and a 2395 bp fragment. This was the same as the positive control SFL1613 (Fig. [4](#Fig4){ref-type="fig"}). No bands were present in the negative control.Fig. 4Southern Blot of *Eco*32I digested chromosomal DNA with a *gtrIC* probe. i. Agarose gel of digested genomic DNA. ii. Southern blot analysis of digested genomic DNA. **a** Egyptian serotype 1c strains. Lane 1. Marker SPP-I/*Eco*RI; 2. SFL1613 (control strain); 3. SFL1683; 4. SFL1684; 5. SFL1686; 6.SFL1687; 7. SFL1688; 8.SFL1689; 9. SFL1690; 10.SFL1691; 11.SFL1692; 12. SFL1685. **b** Bangladeshi serotype 1c strains. Lane 1. Marker SPP-I/*Eco*RI; 2. SFL1613 (control strain); 3. SFL1500; 4. SFL1502; 5. SFL1503. **c** Vietnamese (Son Tay Province) serotype 1c strains. Lane 1. SPP-I/*Eco*RI; 2. SFL1613 (control strain); 3. SFL1564; 4. SFL1568; 5. SFL1569; 6.SFL1571; 7. SFL1575; 8.SFL1576; 9. SFL1577; 10.SFL1578; 11.SFL1579; 12. SFL1570. **d** Vietnamese Serotype 1c strains - Son Tay Province. (Isenbarger et al. 2001). Lane 1. SFL1580; 2. SFL1581; 3. SFL1582; 4. SFL1583; 5. SFL1584; 6.SFL1585; 7. SFL1586; 8.SFL1587; 9. SFL1588; 10.SFL1589; 11.SFL1590; 12. SFL1594.; 13.SFL1596; 14. SFL1597. 15.SFL1598; 16. SFL1600; 17.SFL1602; 18. SFL1603;19. SFL1613 (positive control strain) 20. Marker SPP-I/*Eco*RI. **e** Nha Trang, Vietnam (5 from Isenbarger et al. 2001, 13 from Prof. Cam PD). Lane 1. Marker SPP-I/*Eco*RI; 2. SFL1604; 3. SFL1605; 4. SFL1606; 5. SFL1607; 6.SFL1610; 7. SFL1556; 8.SFL1557; 9. SFL1558; 10.SFL1561; 11.SFL1562; 12. SFL1565.; 13.SFL1566; 14. SFL1567. 15.SFL1572; 16. SFL1573; 17.SFL1599; 18. SFL1712;19. SFL1613 (positive control strain) 20. Marker SPP-I/*Xba*I

*Bam*HI-digested genomic DNA was used to examine the genetic arrangement of the downstream region of *gtrIC*. In all the serotype 1c strains evaluated (one Bangladeshi, four Egyptian, four Vietnamese from Son Tay province, and four Vietnamese from NhaTrang province), one band corresponding to the 12,500 bp fragment was observed when probed with *gtrIC* (Additional file [1](#MOESM1){ref-type="media"}: Figure S1).

The findings from both sets of Southern blot analysis show that all the serotype 1c strains had the same genetic organization upstream and downstream of the *gtrIC* cluster, despite their different geographic origins; also, that they were flanked by the same insertion sequences and located next to the *yejO* locus (Additional file [2](#MOESM2){ref-type="media"}: Figure S2). As the serotype 1c strains used in this Southern hybridization study were obtained from several different geographic locations, it would have been reasonable to expect that these *S. flexneri* isolates would have different structures of the *gtrIC* cluster. Moreover, some might well have contained an intact bacteriophage or prophage sequence, which would have resulted in different genetic arrangements of the sequence surrounding the *gtrIC* gene. However, our findings surprisingly showed the organization of the *gtrIC* gene cluster to be universal and conserved in all the *S. flexneri* serotype 1c strains examined. The Southern hybridization results also revealed that only one copy of *gtrIC* was present in all of the tested strains -- which suggests that all the serotype 1c strains are likely to have originated from a single clone.

Findings like ours are not unique. Similar findings were also reported in *Streptococcus pneumoniae*, with different types of 37 clinical isolates from two different continents (Europe and America) having an identical *tts* gene directing the formation of type 37 capsular polysaccharide \[[@CR9]\]. These isolates too constituted a highly related strain cluster (clonal complex), suggesting that every type 37 pneumococcus found globally had originated from a single parental clone.

In the same vein, a study conducted by Frosch et al. \[[@CR10]\] using Southern blot analysis revealed a strong homology between the functional regions of the *cps* locus of different meningococcal serogroups. A further study by Frosch et al. \[[@CR11]\] showed the molecular organization of the capsule gene (*cps*) loci in different serogroups of *Neisseria meningitidis* to be very similar to that of *E. coli* and *Haemophilus influenzae.* These authors concluded that the strongly homologous organization of the capsule gene loci in *N. meningitidis*, *E. coli* and *H. influenzae* point to a common evolutionary origin of capsule production in Gram-negative bacteria expressing group II capsular polysaccharides.

Origin of the *gtrIC* modification in *S. flexneri* serotype 1c strains {#Sec11}
-----------------------------------------------------------------------

The *gtrIC* modification we observed may have originated either through a serotype 1a strain gaining the *gtrIC* or through a serotype 1c strain losing the *gtrIC* function. If a serotype 1a strain was derived from an ancestral serotype 1c strain, due to the *gtrIC* cluster in the serotype 1a strain having been disrupted by either insertion elements or through gene deletion, then remnant(s) of the *gtrIC* gene or the gene cluster would exist in the genome of serotype 1a strains (Additional file [3](#MOESM3){ref-type="media"}: Figure S3).

In order to investigate if remnants of the *gtrIC* gene or gene cluster exist in serotype 1a strains, a Southern blot analysis was performed using the *gtrIC* and *gtrIC* cluster probes. Serotype 1b strains were also included in this analysis because they have the same α1➔4 linkage to N-acetylGlc as serotype 1a strains. All together six serotype 1a and thirteen serotype 1b strains, isolated from Bangladesh, the UK and Japan, were analysed with Southern blotting. The genomic DNAs from these strains were digested with *Eco*32I and probed with DIG-labelled *gtrIC*. None of the screened serotype 1a or serotype 1b strains showed a detectable *gtrIC* gene remnant (Fig. [5a](#Fig5){ref-type="fig"} and [b](#Fig5){ref-type="fig"}).Fig. 5Southern Blot of *Eco*32I-digested chromosomal DNA. i. Agarose gel of digested genomic DNA. ii. Southern blot analysis of digested genomic DNA. **a** Bangladeshi, and Japanese serotypes 1a and 1b strains, with a *gtrIC* probe. Lane 1. Marker SPP-I/*Eco*RI; 2. SFL1613 (control strain); 3. SFL1287 (1a-Jpn); 4. SFL1288 (1a-Jpn); 5. SFL1492 (1a-Bangladesh); 6.SFL1493(1a-Bangladesh); 7. SFL1494(1a-Bangladesh); 8.SFL1495(1a-Bangladesh); 9. SFL1496(1b-Bangladesh); 10.SFL1497(1b-Bangladesh); 11.SFL1498(1b-Bangladesh); 12. SFL1499(1b-Bangladesh). **b** UK and Japanese serotype 1b strains, with a *gtrIC* probe. Lane 1. Marker SPP-I/*Eco*RI; 2. SFL1613 (control strain); 3. B1118 (control negative strain); 4. SFL1417 (1b-NCTC-UK); 5. SFL276 (1b-Japan); 6.SFL1289(1b-Japan); 7. SFL1300(1b-Japan); 8.SFL1309(1b-Japan); 9. SFL1315(1b-Japan); 10.SFL1316(1b-Japan); 11.SFL1277(1b-rough-Japan); 12. SFL1278(1b-rough-Japan). **c** Ten selected UK, Bangladeshi and Japanese serotype 1b strains, with a *gtrIC* cluster probe. Lane 1. SPP-I/*Eco*RI; 2. SFL1613 (control strain); 3. SFL1287(1a-Japan); 4. SFL1300 (1b-NCTC-UK); 5. SFL1315 (1b-Japan); 6.SFL1316(1b-Japan); 7. SFL1499(1b-B); 8.SFL1498(1b-Rough); 9. SFL1497(1b-B); 10.SFL1496(1b-B); 11.SFL1417(1b-UK); 12. SFL1277(1b-rough-Japan)

Additional Southern blotting with *gtrIC* cluster as a probe was then performed to confirm the results obtained. We thought that the *gtrIC* cluster (containing the *gtrA*~*Ic*~, *gtrB*~*Ic*~ and *gtrIC* genes as an operon) would be able to act as a more comprehensive probe to detect remnants of *gtrA*~*Ic*~, *gtrB*~*Ic*~ and *gtrIC*. Ten of the previously screened 1a and 1b strains were selected for this additional assay. Other than the control SFL1613 strain, which showed two bands of 2395 and 7784 bp as expected, the rest of the samples did not produce any significant band (Fig. [5c](#Fig5){ref-type="fig"}). This clearly confirmed that no remnant of *gtrA*~*Ic*~, *gtrB*~*Ic*~ or *gtrIC* existed in any of the screened serotype 1a and 1b strains.

The lack of the *gtrIC* gene specifically, and more broadly of the *gtrIC* gene cluster, from the genomic DNA of the serotype 1a and 1b strains indicates that the *gtrIC* cluster did not exist in an ancestor of the serotype 1a or 1b strains. This finding thus rules out the "loss of *gtrIC* function" hypothesis, and proves that serotype 1a/1b strains did not derive from a serotype 1c strain. The more likely explanation, therefore, is that the *gtrIC* cluster was inserted into an *S. flexneri* serotype 1a strain via a bacteriophage. This hypothesis is consistent with the findings from the analysis of the sequence surrounding the *gtrIC* and *gtrI* clusters in serotype 1c strains.

Presence of *EPEC* gene in *S. flexneri* serotype 1c strains and sequences surrounding *gtrIC* cluster {#Sec12}
------------------------------------------------------------------------------------------------------

We had previously studied a 7241 bp upstream and 11,906 bp downstream region surrounding the *gtrIC* cluster in SFL1613 and shown this to contain the IS629 isoform, ISEhe3 fragment, hypothetical ORF proteins and several housekeeping genes (*yejO, narP, ccmH, dsbE, ccm*) at the 3′ end, as well as insertion elements (IS911 interrupted three times by IS30, a group II intron and a putative transposase) at the 5′end \[[@CR5]\]. A continuous 4700 bp sequence of the 7241 bp nucleotide upstream was 98 % identical to a region in the pB171 plasmid of the Enteropathogenic *E. coli*. Therefore, in order to identify whether SFL1613 contained any further sequence in common with pB171, additional sequencing (further upstream of the previously published 7.2 kb sequence) was performed. A stretch of the 10,243 bp nucleotide sequence further upstream of the *gtrIC* gene cluster was obtained by primer walking. A bioinformatics analysis of the 10,243 bp sequence revealed 21 putative open reading frames (ORFs); of which 17 were complete and 4 incomplete. Of the 17 complete ORFs, 16 were predicted to encode proteins which were significantly homologous with known proteins, while 1 ORF had no region of significant homology with proteins in the current database (Fig. [6](#Fig6){ref-type="fig"} and Table [3](#Tab3){ref-type="table"}).Fig. 6Linear representation of the 10,243 bp nucleotide sequence further upstream from the previously sequenced *gtrIC* cluster in SFL1613. The first line shows the nucleotide sequence scale in base pairs. The second and third lines show the distribution of all ORFs, with horizontal arrows denoting the direction of transcription. Dark blue represents ORF in the prophage integrase region, light blue represents ORFs in the insertion sequence regionTable 3Sequence analysis of the 10243 bp fragment further upstream of *gtrIC* clusterORF (gene name) or featureNt position^a^Gene size (bp)No of amino acids encodedDatabase search resultsFeature or protein (Saiz, aa)Source (accession no.)Identity (%)Positive (%)BlastP *E* value*orf 1' (ndpA* or *yejK)*Complement (1..332)332 of 1007111Nucleoid-associated protein ndpA (335aa)*Shigella flexneri* K-272 (EGK22467.1)110/110 (100 %)110/110 (100 %)7e-72DNA-associated protein (335aa)*Escherichia coli* BL21(DE3)(YP_002999856.1)110/110 (100 %)110/110 (100 %)8e-72Nucleoid-associated protein NdpA (335aa)*Shigella boydii* Sb227 (YP_408543.1)110/110 (100 %)110/110 (100 %)8e-72*Shigella boydii* CDC 3083-94Nucleoid-associated protein YejK (335aa)(YP_001879481.1)110/110 (100 %)110/110 (100 %)8e-72*orf 2*331..47714748Hypothetical prot. HMPREF9346_02485, (48aa)*Escherichia coli* MS 119--7 (ZP_07102777.1)48/48 (100 %)48/48 (100 %)7e-26Hypothetical prot. HMPREF9552_01955, (48aa)*Escherichia coli* MS 198-1(ZP_07116146.1)48/48 (100 %)48/48 (100 %)7e-26Hypothetical prot. HMPREF9547_02658, (48aa)*Escherichia coli* MS 175--1 (ZP_07169115.1)48/48 (100 %)48/48 (100 %)7e-26Putative ABC transporter permease protein,(303aa)*Streptomyces roseosporus*13/25 (52 %)17/25 (68 %)8.6NRRL11379(ZP_04709202.1)ABC transporter permease protein, (303aa)*Streptomyces roseosporus* NRRL13/25 (52 %)17/25 (68 %)8.615998(ZP_06584909.1)ABC transporter permease protein (303aa)*Streptomyces roseosporus* NRRL13/25 (52 %)17/25 (68 %)8.615998 (EFE75370.1)*orf 3*Complement (377..493)11738Hypothetical prot. ECSTEC7V_2603, (54aa)*Escherichia coli* STEC_7v (EGE64095.1)38/38 (100 %)38/38 (100 %)4e-19hypothetical prot. EcE24377A_2485, (39aa)*Escherichia coli* E24377A (YP_001463540.1)38/38 (100 %)38/38 (100 %)9e-19Hypothetical protein EcHS_A2325, (39aa)*Escherichia coli* HS (YP_001458987.1)38/38 (100 %)38/38 (100 %)9e-19Hypothetical protein SbBS512_E077(39aa)*Shigella boydii* CDC 3083--94 (YP_001879480.1)38/38 (100 %)38/38 (100 %)9e-19*orf 4 (yejL)*514..74122875*yejL* gene product (75aa)*Shigella flexneri* 2a str. 301(NP_708086.1)75/75 (100 %)75/75 (100 %)5e-46Hypothetical protein S2403(75aa)*Shigella flexneri* 2a str. 2457 T (NP_837801.1)Hypothetical protein SFV_2265 (75aa)*Shigella flexneri* 5 str. 8401 (YP_689686.1)*orf 5 (yejM)*761..25211761586 (2 domains detected)*yejM* gene product (586aa)*Shigella flexneri* 2a str. 301(NP_708087.1)586/586 (100 %)586/586 (100 %)0.0Sulfatase (586aa)*Shigella flexneri* 2a str. 2457 T (NP_837802.1)*yejM* gene product (586aa)*Shigella flexneri* 2002017 (YP_005727919.1)*tRNA-Pro*2596..266974NA*tRNA-Pro* (74 bp)*Escherichia coli* str. K-12 substr. W3110 (NC_007779.1)74/74 (100 %)^c^NA1e-30^c^*orf 6*Complement (1838..2164)327108No significant homology*orf 7 (int)*2879..41231245414Prophage integrase (413aa)*Shigella boydii* CDC 3083--94 (YP_001879477.1)412/412 (100 %)412/412 (100 %)0.0Prophage CP4-57 integrase (414aa)*Escherichia coli* TX1999 (EGX23085.1)408/414 (99 %)410/414 (99 %)0.0integrase (414aa)*Escherichia coli* 042 (YP_006096729.1)403/414 (97 %)409/414 (99 %)0.0*orf 8*4398..458919263Putative prophage regulatory protein (63aa)*Escherichia coli* 042 (YP_006096730.1)59/63 (94 %)63/63 (100 %)4e-35Hypothetical prot. SbBS512_E0760 (51aa)*Shigella boydii* CDC 3083--94 (YP_001879474.1)49/51 (96 %)51/51 (100 %)2e-27Transcriptional regulator, AlpA family (68aa)*Escherichia coli* 53638 (ZP_03002982.1)43/61 (70 %)52/61 (85 %)2e-24CP4-57 regulatory protein (AlpA) family protein (68aa)*Escherichia coli* UMNF18 (AEJ57337.1)42/61 (69 %)52/61 (85 %)3e-24*orf 9*4816..5412597198 *\[F + 1\]*Putative prophage protein (198aa)*Escherichia coli* 042 (YP_006096731.1)165/198 (83 %)171/198 (86 %)4e-114Putative prophage protein (198aa)*Escherichia coli* DEC7A (EHV77794.1)151/198 (76 %)163/198 (82 %)7e-100Immunity region (569aa)*Escherichia coli* STEC_94C78/153 (51 %)96/153 (63 %)2e-34*orf 10*5235..542318962 *\[F + 3\]*Hypothetical prot. SbBS512_E0759 (62aa)*Shigella boydii* CDC 3083--94 (YP_001879473.1)62/62 (100 %)62/62 (100 %)1e-37Hypothetical protein SFK315_2596 (62aa)*Shigella flexneri* K-315 (EIQ20710.1)61/62 (98 %)61/62 (98 %)4e-36Conserved hypothetical protein (62aa)*Escherichia albertii* TW07627 (ZP_02901801.1)50/62 (81 %)53/62 (85 %)3e-29*orf 11*5416..560118661Hypothetical prot. SbBS512_E0758 (61aa)*Shigella boydii* CDC 3083--94 (YP_001879472.1)61/61 (100 %)61/61 (100 %)3e-35Putative prophage protein (61aa)*Escherichia coli* 042 (YP_006096732.1)60/61 (98 %)60/61 (98 %)5e-34*orf 12*complement (5536..5949)414137Hypothetical prot. ECe0006 (95aa)*Escherichia coli* (ABM53624.1)43/92 (47 %)54/92 (59 %)6e-18Hypothetical prot. c1494(95aa)*Escherichia coli* CFT073 (NP_753403.1)44/93 (47 %)55/93 (59 %)9e-18Hypothetical prot. SBO_2130 (95aa)*Shigella boydii* Sb227 (YP_408537.1)42/92 (46 %)53/92 (58 %)2e-17*orf 13*5641..594030099Hypothetical prot. SbBS512_E0757 (99aa)Shigella boydii CDC 3083--94 (YP_001879471.1)99/99 (100 %)99/99 (100 %)2e-67Hypothetical prot. EcoM_00008 (99aa)*Escherichia coli* WV_060327(EFW72294.1)76/99 (77 %)82/99 (83 %)1e-47Hypothetical bacteriophage prot.(99aa)*Escherichia coli* H299 (ZP_08382870.1)75/99 (76 %)81/99 (82 %)6e-47Hypothetical bacteriophage prot.(99aa)*Shigella dysenteriae* 1012 (ZP_03066472.1)72/99 (73 %)79/99 (80 %)1e-44Bacteriophage protein (99aa)*Shigella flexneri* 2a str. 301(NP_707045.1)67/99 (68 %)78/99 (79 %)1e-41*orf 14*5937..8072 bacteriophage P4-DNA primease2136711Hypothetical prot. SbBS512_E0756 (711aa)*Shigella boydii* CDC 3083--94 (YP_001879470.1)711/711 (100 %)711/711 (100 %)0.0Hypothetical prot. SFK315_2598 (711aa)*Shigella flexneri* K-315 (EIQ20712.1)674/709 (95 %)691/709 (97 %)0.0Putative prophage protein(712aa)*Escherichia coli* 042 (YP_006096734.1)630/712 (88 %)658/712 (92 %)0.0Putative prophage DNA primase (711aa)*Escherichia coli* DEC7A,C,D,E, EPECa12(EHV77797.1,86415.1, 91550.1, EHW01270.1 EIQ62754.1)621/711 (87 %)652/711 (92 %)0.0DNA Primease, phage-associated (713aa)*Escherichia coli* PA5 (ZP_02787536.1)563/713 (79 %)618/713 (87 %)0.0Putative prophage primase (693aa)*Escherichia coli* 042 (YP_006096469.1)520/693 (75 %)579/693 (84 %)0.0*orf 15'*8309..850019264Putative single stranded DNA-binding protein (141aa)*Shigella boydii* CDC 3083--94 (YP_001879469.1)64/64 (100 %)64/64 (100 %)3e-38Putative single stranded DNA-binding protein of prophage (136aa)*Escherichia coli* IAI39 (YP_002407987.1)59/64 (92 %)62/64 (97 %)9e-35Putative single-strand DNA binding prophage protein (141aa)*Escherichia coli* 042 (ref\|YP_006096735.1)60/64 (94 %)62/64 (97 %)1e-34*orf 16*8580..884626788transposase (88aa)*Escherichia coli* CFT073 (NP_754364.1)86/88 (98 %)88/88 (100 %)2e-55transposase (88aa)*Escherichia coli* UTI89 (YP_541223.1)86/88 (98 %)86/88 (98 %)86/88 (98 %)IS1400 transposase A (88aa)*Escherichia coli* 536 (YP_669883.1)trp1400A gene product (95aa)*Erwinia billingiae* Eb661(YP_003743077.1)81/88 (92 %)87/88 (99 %)3e-52IS1400 transposase A (95aa)*Yersinia enterocolitica* subsp. enterocolitica 8081 (YP_001004058.1)80/88 (91 %)86/88 (98 %)6e-52*orf 17*9212..9691480159Insertion element IS407 family protein(159aa)*Escherichia coli* MS 107--1 (ZP_07096798.1)151/159 (95 %)156/159 (98 %)8e-109transposase B (182aa)*Edwardsiella ictaluri* 93--146 (YP_002932372.1)151/159 (95 %)152/159 (96 %)7e-108Integrase core domain-containing protein (236aa)*Escherichia fergusonii* B253 (EGC09228.1)151/159 (95 %)156/159 (98 %)2e-107InsK (207aa)*Salmonella enterica* subsp. enterica serovar Montevideo str. SARB31 (EHL38295.1)150/159 (94 %)155/159 (97 %)1e-106Transposase B (233aa)*Salmonella enterica* subsp. enterica serovar Kentucky str. CDC 191 (ZP_03224077.1)151/159 (95 %)156/159 (98 %)2e-106IS1400 transposase B (159aa)*Escherichia coli* 536 (YP_669884.1)148/159 (93 %)152/159 (96 %)2e-106*orf 18*8580..96911112370Putative transposase (370aa)*Salmonella enterica* subsp. VII (CAX68025.1)351/370 (95 %)358/370 (97 %)0.0Transposase (370aa)*Salmonella enterica* subsp. enterica serovar Enteritidis str. P125109 (YP_002244693.1)350/370 (95 %)352/370 (95 %)0.0Transposase (370aa)*Salmonella enterica* subsp. enterica serovar Gallinarum str. 287/91 (YP_002227530.1)349/370 (94 %)349/370 (94 %)0.0*Orf19*Complement (8843..9217)375122Hypothetical prot. HMPREF9345_01631(122aa)*Escherichia coli* MS 107--1 (ZP_07096799.1)108/122 (89 %)115/122 (94 %)1e-74Hypothetical protein UUU_27350 (124aa)*Klebsiella pneumoniae* subsp. pneumoniae DSM 30104 (EJK89616.1)100/124 (81 %)111/124 (90 %)5e-68*orf 20'*10055..1015610234Transposase family protein (63aa)*Shigella flexneri* J1713 (gb\|EGM62085.1)34/34 (100 %)34/34 (100 %)1e-15Transposase IS3/IS911 (40aa)*Shigella flexneri* K-218 (EGK22768.1)34/34 (100 %)34/34 (100 %)1e-15ISEhe3 orfA (71aa)*Shigella sonnei* 53G (YP_005457329.1)34/34 (100 %)34/34 (100 %)1e-15ISEhe3 orfA (92aa)*Shigella flexneri* 5 str. 8401 (YP_688117.1)34/34 (100 %)34/34 (100 %)2e-15ISEhe3 orfA (92aa)*Shigella flexneri* 2a str. 2457 T (NP_836231.1)34/34 (100 %)34/34 (100 %)2e-15*orf 21'*10157..1024387NAInsertion sequence IS911 (1250 bp)^c^*Shigella dysenteriae* (X17613.1)86/87 (99 %)^c^NA2e-35^ca^The position relative to the 10,244 bp fragment is indicated^b^NA, not applicable'Partial open reading frame^c^On the basis of nucleotide sequence homology, percentage and E-value of BlastN database search*Note*: all nt positions include the stop codon, while the aa length does not include the stop codon

2521 bp of sequence at the beginning of the 10,243 bp sequence is a section of a sequence region which corresponds to the *S. flexneri* house-keeping genes *yejK* (*orf 1'*), *yejL* (*orf 4*), *yejM* (*orf 5*), and to hypothetical proteins (*orf 2, 3& 6*) (Fig. [6](#Fig6){ref-type="fig"} and Table [3](#Tab3){ref-type="table"}). Further sequence analysis found this stretch of the SFL1613 sequence to be \>99 % identical to that found in the *S. flexneri* serotype 2a strain 2457 T. A BlastP search revealed that the protein encoded by *orf 6* has no significant homology to any existing protein in the database. Meanwhile, the protein encoded by *orf-7* exhibited a high level of homology (E-value of 0.0) and 100 % (413/413aa) identity with a prophage integrase of *Shigella boydii* CDC3083-94 (NC_010658.1) (Table [3](#Tab3){ref-type="table"}). Interestingly, the tRNA^Pro^ which was not identified in the previously published 19.1 kb fragment \[[@CR5]\] was identified in this extended 10.2 kb fragment. It is located 210 bp upstream of the prophage integrase (Fig. [6](#Fig6){ref-type="fig"}).

It is also noteworthy that a tRNA^Pro^ gene, previously identified as being located between the *yejM* and *yejO* genes in *S. flexneri* serotype 2a (2457 T) and serotype 5a (8401) strains \[[@CR12], [@CR13]\], was found by this study to be located in the region upstream of the *gtrIC* cluster and adjacent to the *yejM*. These findings, together with the fact that prophage integrase and prophage related genes were located beside the tRNA^Pro^ gene, strongly suggest that the integration of a bacteriophage appears to have occurred in SFL1613, via the tRNA^Pro^site. The tRNA genes have previously been shown to be a common integration site for bacteriophage \[[@CR14]--[@CR16]\].

Four kb downstream of the prophage integrase and tRNA^Pro^ is a stretch of sequence code for *orf-8* to *orf-15'* proteins, whose functions are known to be associated with the bacteriophage lifestyle. This includes a truncated Xsingle stranded DNA-binding prophage protein, plus a few complete prophage hypothetical proteins such as a putative prophage regulatory protein, three putative prophage proteins, a bacteriophage DNA primase and prophage integrase, as annotated in the genome of *E. coli* 042 (gene bank accession number NC017626.1) \[[@CR17]\]. This suggests that this stretch of sequence (upstream of the *gtrIC* cluser) was in fact derived from a phage.

Immediately upstream of the previously published 7241 bp sequence is a stretch of a sequence region which has significant homology to a number of insertion elements such as IS1400 (*orfs 16--18*), a hypothetical protein (*orf 19*), ISEhe3 (*orf 20'*), and IS911(*orf 21'*), all related to *Shigella spp, Salmonella spp and E. coli*. Conserved domains were detected in *orf-16* from the NCBI's Conserved Domains Database*.* The highest scoring match was the HTH Hin-like domain, which is a family of DNA-binding domains unique to bacteria and represented by the Hin protein of *Salmonella*. The Hin recombinase induces the site-specific inversion of a chromosomal DNA segment containing a promoter, which controls the alternate expression of two genes by reversibly switching orientation. The rve_3 (pfam13683), integrase core domain, which mediates integration of a DNA copy of the viral genome into the host chromosome, was detected in *orf-17* \[[@CR18]\].

Database searches and careful analysis of the 10,243 bp of nucleotide sequence and corresponding proteins in this region revealed no further sequence common to pB171 of EPEC.

The sequencing results of the 19.1 kb published sequence plus the extended 10.2 kb sequence (obtained from this study) clearly indicate that the organization of the *att* sites, *glucosyltransferase* (*gtrIC*) genes and *int* in the SFL1613 chromosome is reminiscent of a prophage, although it appears that more than half of the phage genome has been deleted. Our results also suggest that tRNA^Pro^ (upstream of the *gtrIC* gene cluster) and the *yejO* locus (downstream of *gtrIC* gene cluster) define the boundaries of the phage DNA in this area of the SFL1613 chromosome. A homology analysis of the proteins encoded by *orf 8* through *orf 15'* suggests that this region of the sequence is a prophage-related sequence. Furthermore, a Blast search matching with the enteroaggregative *E. coli* (EAEC) strain 042 database suggests that the 2 kb sequence downstream of the *gtrIC* cluster, located between the *yejO* locus and the IS*629*, is in fact derived from a phage \[[@CR5]\]. These two findings clearly show that both the upstream and downstream of the *gtrIC* cluster are composed of prophage sequences which have been disrupted by various mobile genetic elements.

Another interesting observation to emerge from this study was the presence of at least 8 different insertion sequences in both the 19.1 kb and the extended 10.2 kb fragments (see Fig. [6](#Fig6){ref-type="fig"} and Additional file [2](#MOESM2){ref-type="media"}: Figure S2). Given the large number of insertion sequences occurring in this region, it is reasonable to assume that the insertion of bacteriophage via the tRNA^Pro^ site (*attL*) was subsequently disrupted by insertion elements and consequently resulted in the deletion of the *attR* site of the tRNA^Pro^ in SFL1613.

Conclusion {#Sec13}
==========

This study provides molecular insights into the novel *S. flexneri* serotype 1c strain, as well as the *gtrIC* gene cluster that drives its unique immune recognition. This is the first study to show that serotype 1c isolates share an identical pattern of genetic arrangement despite their differing geographic origins, suggesting that serotype 1c strains may have originated from a single parental strain. The gene cluster responsible for Type 1C modification appears to have emerged in the *S. flexneri* serotype 1a via a bacteriophage integrated into the tRNA^Pro^ locus.

These findings expand our knowledge of the Type 1C modification of *Shigella*, and shed light on the genetic distribution of the *gtrIC* locus in serotype 1c strains. This new information will be useful for future *Shigella* research, and particularly for the design of safe and effective multivalent or cross-reactive vaccines against shigellosis.
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Additional file 1: Figure S1.\*Southern blot of *Bam*HI-digested genomic DNA probe with the *gtrIC* gene. (i) Agarose gel of digested genomic DNA. (ii) Southern blot analysis of digested genomic DNA. Lane 1. SPP-I/*Xba*I; 2. SFL1502; 3. SFL1684; 4. SFL1685; 5. SFL1686; 6.SFL1687; 7. SFL1575; 8.SFL1576; 9. SFL1578; 10.SFL1579; 11.SFL1556; 12. SFL1557.; 13.SFL1558; 14. SFL1712; 15.SFL1613; 16. Marker SPP-I/*Eco*RI. (DOCX 240 kb)Additional file 2: Figure S2.\*The *gtrIC* cluster and surrounding 19,147 bp sequence in serotype 1c strain SFL1613 \[[@CR5]\]. (DOCX 114 kb)Additional file 3: Figure S3.\*Schematic diagram illustrating two hypotheses that could potentially explain the evolution of the serotype 1c strain. (A) The *gtrIC* insertion hypothesis. (B) The deletion of *gtrIC* hypothesis causing the loss of functional gtrIc modification. (DOCX 115 kb)
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